Genome-wide CRISPR-based gene knockout screens reveal cellular factors and pathways essential for nasopharyngeal carcinoma.
Chong WangSizun JiangLiangru KeLuyao ZhangDifei LiJun LiangYohei NaritaIsabella HouChen-Hao ChenLiang Wei WangQian ZhongYihong LingXing LvYanqun XiangXiang GuoMingxiang TengSai-Wah TsaoBenjamin E GewurzMu-Sheng ZengBo ZhaoPublished in: The Journal of biological chemistry (2019)
Early diagnosis of nasopharyngeal carcinoma (NPC) is difficult because of a lack of specific symptoms. Many patients have advanced disease at diagnosis, and these patients respond poorly to treatment. New treatments are therefore needed to improve the outcome of NPC. To better understand the molecular pathogenesis of NPC, here we used an NPC cell line in a genome-wide CRISPR-based knockout screen to identify the cellular factors and pathways essential for NPC (i.e. dependence factors). This screen identified the Moz, Ybf2/Sas3, Sas2, Tip60 histone acetyl transferase complex, NF-κB signaling, purine synthesis, and linear ubiquitination pathways; and MDM2 proto-oncogene as NPC dependence factors/pathways. Using gene knock out, complementary DNA rescue, and inhibitor assays, we found that perturbation of these pathways greatly reduces the growth of NPC cell lines but does not affect growth of SV40-immortalized normal nasopharyngeal epithelial cells. These results suggest that targeting these pathways/proteins may hold promise for achieving better treatment of patients with NPC.
Keyphrases
- genome wide
- dna methylation
- end stage renal disease
- copy number
- ejection fraction
- high throughput
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- gene expression
- oxidative stress
- single molecule
- transcription factor
- immune response
- artificial intelligence
- pi k akt
- respiratory tract
- genome wide identification